Cloning of human telomerase catalytic subunit gene promoter and studying on its specific transcriptional activities in human lung cancer cells

Chinese Journal of Lung Cancer

Volumn 7, Issue 6, 2004, Pages 475-479

  Tang, Xiaojun ^a   Wang, Yanping ^a   Zhou, Qinghua ^a   Zhu, Wen ^a   Che, Guowei ^a   Chen, Xiaohe ^a   Zhu, Daxing ^a   Sun, Zhilin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

hTERT; Lung neoplasms; Promoter; Transcriptional activity

Indexed keywords

DNA; LUCIFERASE; TELOMERASE REVERSE TRANSCRIPTASE;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DNA SEQUENCE; ELECTROPHORESIS; GENE THERAPY; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG FIBROBLAST; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PROMOTER REGION; RECOMBINANT PLASMID; REPORTER GENE; TRANSCRIPTION INITIATION SITE;

EID: 11244293562     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Quan S, Pan GZ, Lu CM, et al. Experimental studies in vitro on the alpha-fetoprotein-specific promoter mediated target gene therapy of hepatocellular carcinoma. Acta Acad Med Sinic, 1999, 21 (2): 111-117.
2. Humphreys MJ, Ghaneh P, Greenhalf W, et al. Hepatic intra-arterial delivery of a retroviral vector expressing the cytosine deaminase gene, controlled by the CEA promoter and intraperitoneal treatment with 5-fluorocytosine suppresses growth of colorectal liver metastases. Gene Ther, 2001, 8(16): 1241-1247.
3. Gotoh A, Ko SC, Shirakawa T, et al. Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer. J Urol, 1998, 160(1): 220-229.
4. Wang YP, Zhou QH. Advances in anti-telomerase activity in the treatment of tumor. Chin J Lung Cancer, 2003, 6(5): 402-405.
5. Yao K, Min JX, Zhang GQ, et al. Study on the inhibitory effect of antisense PNA of telomerase for growth of lung cancer cell lines in vitro. Chin J Lung Cancer, 2004, 7(3): 196-198.
6. Zhou X, Li LY. Advances in telomerase inhibitors. Chin J Lung Cancer, 2003, 6(1): 86-88.
7. Hahn WC. Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol, 2003, 21(10): 2034-2043.
8. Horikawa I, Cable PL, Afshari C, et al. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene. Cancer Res, 1999, 59(4): 826-830.
9. Huang JJ, Li JZ, Lin J, et al. Cloning and characterization of human telomerase catalytic subunit (hTERT) gene promoter. Lett Biotechnol, 1999, 10(3): 167-170.
10. Cong YS, Wen J, Bacchetti S. The human telomerase catalytic subunit hTERT: organization of the gene and characterization of the promoter. Hum Mol Genet, 1999, 8(1): 137-142.
11. Takakura M, Kyo S, Kanaya T, et al. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells. Cancer Res, 1999, 59(3): 551-557.
12. Yang YJ, Zheng XF, Zhu J, et al. Construction of telomerase specific cells expression vector utilizing the human telomerase catalytic subunit gene promoter. Chin J Biochem Mol Biol, 2003, 19(4): 533-536.
13. Komata T, Koga S, Hirohata S, et al. A novel treatment of human malignant gliomas in vitro and in vivo: FADD gene transfer under the control of the human telomerase reverse transcriptase gene promoter. Int J Oncol, 2001, 19(5): 1015-1020.